Florence Chaverneff, PhD

Ofatumumab was found to have greater efficacy than teriflunomide for the treatment of patients with newly diagnosed relapsing multiple sclerosis.

Individuals with migraine who are obese may have reduced migraine frequency, lower pain intensity, shorter attack duration, and improved disability after losing weight.

Individuals with migraine who are obese may have reduced migraine frequency, lower pain intensity, shorter attack duration, and improved disability after losing weight.

Transcutaneous electrical nerve stimulation administered during physical activity may effectively alleviate fibromyalgia-associated pain, fatigue, and disease impact in women.

A “Pain and Stress Management” program for the management of chronic pain, was found to be effective in alleviating pain, diminishing stress, promoting self-management of pain, and ameliorating general well-being.

Eptinezumab has shown 100% bioavailability when administered intravenously.

Treatment with fremanezumab may help reduce medication overuse and the number of days of acute medication use in individuals with chronic migraine.

Individuals with chronic migraine may present with age-related changes in cortical thickness.

Individuals with chronic vs episodic migraine may be more likely to experience chronic back pain, chronic pain, neck pain, anxiety, and depression.

Eptinezumab, a humanized monoclonal antibody specific to calcitonin gene-related peptide, may be an effective prophylactic for individuals with frequent episodic migraines.

Obesity-associated lowering of vitamin D levels may not mediate the putative causal relationship between obesity and multiple sclerosis.

In patients with multiple sclerosis, lesions in the right dorsolateral prefrontal cortex may be associated with hypoalgesia, and lesions in the posterior periventricular area, with hyperalgesia.

Ketamine was found to alleviate a number of pain-related conditions, and a number of clinical trials investigating its efficacy are ongoing.

Headache, dizziness, and psychological factors in patients with vestibular migraine were alleviated by vestibular rehabilitation.

The NASEM report, which was commissioned by the FDA, gives an update on current research in the pain field.

Patients receiving buprenorphine maintenance therapy for their opioid use disorder may have impaired sleep, although they report improvements in both quality and duration of sleep.

Concordance or discordance in pain catastrophizing between parents and children may impact pain coping in children with migraine.

Children with headache and migraine, particularly girls younger than12 years of age, experience premonitory signs.

NINDS program director urged clinicians, researchers, and clinician-scientists to submit grant applications to the NIH, as very few are submitted in the field of migraine and headache research.

Single-pulse transcranial magnetic stimulation may represent an effective prophylactic treatment for migraine.

Children may exhibit different patterns of migraine location and quality compared with adolescents and adults.

Erenumab may represent a safe and efficacious prophylactic treatment for episodic migraine.

Fetal growth restriction is characterized by a birthweight below the tenth percentile, according to gender and gestational age.

Posttraumatic stress disorder is associated with a high incidence of chronic pain; what role headache plays in that relationship is not well known.

Transcranial random noise stimulation improved both physical and cognitive symptoms of fibromyalgia.

The co-presentation of headache at stroke onset in children may provide clues to underlying pathophysiologic mechanisms.

The National Academies of Sciences, Engineering, and Medicine have released a report

Recent findings offer a new avenue for the development of peripheral analgesics with minimal adverse effects.

Fiber optic light at blue and yellow wavelengths can respectively activate and inhibit neurons expressing light-sensitive ion channels

Thalamic theta oscillations may underlie poor neuropathic pain relief following deep brain stimulation.